Evidence map›Paper›PMID 40936400›Full record

ReviewANZ journal of surgery2025

Cutaneous Melanoma Management-An Update and Narrative Review for the General Surgeon.

Matthew Binks, Alexander C J van Akkooi, Alexander M Menzies, Andrew Spillane

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in ANZ journal of surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Matthew BinksMelanoma Institute of Australia, Sydney, New South Wales, Australia.ORCID 0000-0002-8283-5751
Alexander C J van AkkooiMelanoma Institute of Australia, Sydney, New South Wales, Australia.ORCID 0000-0002-3262-6935
Alexander M MenziesMelanoma Institute of Australia, Sydney, New South Wales, Australia.
Andrew SpillaneMelanoma Institute of Australia, Sydney, New South Wales, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsThe multidisciplinary management of cutaneous melanoma is advancing rapidly. Surgeons remain a key entry point for melanoma patients into specialist care and their up-to-date knowledge is vital for patient outcomes.

methodsA narrative review was performed to provide an update for the surgeon working outside of a high-volume melanoma centre.

resultsThis review covers recent developments in the management of both localised and metastatic cutaneous melanoma and how immunotherapy is changing the melanoma landscape.

conclusionThis review offers a review of the literature and perspectives on potential future developments in cutaneous melanoma management from the Melanoma Institute of Australia.

Indexed as

MelanomaSkin NeoplasmsAustraliaCutaneous Malignant MelanomaGeneral SurgeryHumansImmunotherapySurgeonscutaneous melanomaimmunotherapysurgerysurgical oncology

Identifiers

PMID40936400
PMCPMC12571956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.